Asian travelers seek respite in other options as Middle East travel plans stay grounded
Passenger planes sit on the tarmac at Dubai International Airport in Dubai on March 11, 2026. Drones fell near Dubai...
Novo Nordisk A/S
Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his "liberation day" and imposed sweeping tariffs on imports, kicking off a wave...
Inside India newsletter: The worst might not be over for Indian equities
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of "Inside India" — your...
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based...
Stocks making the biggest moves premarket: McCormick, Diageo, Nvidia & more
Check out the companies making the biggest moves premarket: McCormick — Shares rose more than 3% after Unilever confirmed it...
Inside India newsletter: Ikea has high hopes for the country as it stares at a global slowdown
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of Inside India — your...
U.S. executives, from Apple to Eli Lilly, revamp their push into the world's second-largest economy at the China Development Forum
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the China Development...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients,...
Stocks making the biggest moves premarket: Bumble, Hims & Hers Health, Blue Owl, Netskope & more
Check out the companies making headlines before the bell. Bumble — Bumble shares popped about 21% after the dating app...
Jim Cramer's top 10 things to watch in the stock market Tuesday
My top 10 things to watch Friday, March 10 1. Oil prices are sliding this morning on the heels of...
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more
These are some of the stocks posting the largest midday moves. Source link
Stocks making the biggest moves premarket: Hims & Hers Health, oil stocks, Live Nation Entertainment & more
Check out the companies making headlines before the bell. Oil stocks – Oil stocks traded higher as the commodity surged...
Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the U.S., targeting...
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,...
Stocks making the biggest moves midday: KKR, Blackstone, CrowdStrike, International Paper & more
Check out the companies making the biggest moves midday: Financials — The financials sector of the S & P 500...
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby...
Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino's Pizza and more
Check out the companies making headlines before the bell. Arcellx — The biotech stock surged 78% after Gilead Sciences said...
Stocks making the biggest moves midday: Oracle, Cleveland-Cliffs, Kyndryl, Nexstar, Workday, Hims & Hers
Check out some of the companies making the biggest moves midday: Kyndryl Holdings — The IT infrastructure services provider spun...
Stocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and more
Check out the companies making headlines before the bell. Oracle — Shares rose 2% after the technology firm received an...
US signals crackdown on compounded weight-loss drugs; Hims shares tumble
The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss...
